Effectiveness of Pentavalent Rotavirus Vaccine under Conditions of Routine Use in Rwanda

Clinical Infectious Diseases

Volumn 62, Issue , 2016, Pages S208-S212

  Tate, Jacqueline E ^a   Ngabo, Fidele ^b   Donnen, Philippe ^b   Gatera, Maurice ^c   Uwimana, Jeannine ^d   Rugambwa, Celse ^e   Mwenda, Jason M ^e   Parashar, Umesh D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c RWANDA BIOMEDICAL CENTER   (Rwanda)

^d University Teaching Hospital   (Zambia)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

rotavirus; rotavirus vaccine; vaccine effectiveness

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; VACCINE;

ARTICLE; CASE CONTROL STUDY; CHILD; DRUG EFFICACY; ENZYME IMMUNOASSAY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RWANDA; VACCINATION; VIRAL GASTROENTERITIS; AFRICA SOUTH OF THE SAHARA; DIARRHEA; EVALUATION STUDY; GASTROENTERITIS; IMMUNOLOGY; ODDS RATIO; PREVENTIVE HEALTH SERVICE; ROTAVIRUS; ROTAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA; TRENDS; VIROLOGY;

AFRICA SOUTH OF THE SAHARA; CASE-CONTROL STUDIES; DIARRHEA; FEMALE; GASTROENTERITIS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; ODDS RATIO; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; RWANDA; VACCINATION; VACCINE POTENCY; VACCINES, ATTENUATED;

EID: 84965120331     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1016     Document Type: Article

References (10)

1. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14.
2. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98.
3. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33.
4. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22.
5. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009; 84:533-40.
6. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009-conclusions and recommendations. Wkly Epidemiol Rec 2009; 84:517-32.
7. Meeting of the immunization Strategic Advisory Group of Experts, April 2009-conclusions and recommendations. Wkly Epidemiol Rec 2009; 84: 220-36.
8. World Health Organization. Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Geneva, Switzerland: WHO, 2002.
9. Ngabo F, Tate JE, Gatera M, et al. Decline in diarrhea and rotavirus hospitalizations following introduction of pentavalent rotavirus vaccine in Rwanda. Lancet Global Health. In press.
10. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006; 368:323-32.